 您的位置：对照品 > 对照品 > 中药对照品 > |
|
|
|
| 产品基本信息 |
|
| 产品编号：G797750 |
| 产品名称：GSK 923295 |
| 产品CAS：1088965-37-0 |
| 规格含量：50mg |
| 产品价格：面议 |
| 联系我们: |
 |
|
 |
|
|
| 产品详细介绍 |
| 标准品编号: |
G797750 |
| 名称: |
GSK 923295 |
| 别名: |
3-Chloro-N-[(1S)-2-[[2-(dimethylamino)acetyl]amino]-1-[[4-[8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl]phenyl]methyl]ethyl]-4-(1-methylethoxy)-benzamide; 3-Chloro-N-{(1S)-2-[(N,N-dimethylglycyl)amino]-1-[(4-{8-[(1S)-1-hydroxyethyl]imidazo[1,2-a]pyridin-2-yl}phenyl)methyl]ethyl}-4-[(1-methylethyl)oxy]benzamide; GSK 923295A |
| CAS号: |
1088965-37-0 |
| 分子式: |
C₃₂H₃₈ClN₅O₄ |
| 分子量: |
592.13 |
| 种类: |
Research Tools; |
| 应用: |
GSK 923295 is the first potent, CENP-E-selective inhibitor that has been tested in Phase I clinical trials for treatment of Refractory Cancers. |
| 参考文献 |
|
|
|
|
|
|
